跳至主要内容
临床试验/NCT06657248
NCT06657248招募中不适用

Prospective, Multicenter Study Evaluating the Midterm Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Knee Implant

Aesculap AG8 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年4月2日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Aesculap AG
入组人数
150
试验地点
8
主要终点
Functional patient-reported outcome

研究概览

简要总结

The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.

详细描述

The product under investigation is used in routine clinical practice and according to the authorized Instructions for Use (IfU). The data that is obtained in routine clinical use will be documented in an electronical Case Report Form (eCRF). The study's main purpose is the collection of clinical data on the safety and performance of the redesigned univation® XF Pro implant.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for a primary medial unicompartmental knee endoprosthesis
  • Acc. to Instructions for Use:
  • Both cruciate ligaments intact
  • Lateral ligaments intact
  • Leg axis amenable to passive correction
  • Varus deformity under 15°
  • Bending capability of at least 90°
  • Extension deficit no greater than 5-10°
  • Written informed consent of patient
  • Kellgran & Lawrence Score > II (only straight or varus
  • Patients with moderate radiological symptoms
  • Patients without clinical symptoms

排除标准

  • Pregnancy
  • Patient age <18 and > 75 years
  • High risk patients ASA > III

研究组 & 干预措施

univation® XF Pro

Primary medial unicompartmental knee arthroplasty treated with implantation of unicompartmental knee prosthesis univation® XF Pro

干预措施: univation® XF Pro (Device)

结局指标

主要结局

Functional patient-reported outcome

时间窗: 5 years post-op

The Oxford Knee Score (OKS) is a reliable 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing total knee replacement. It is short, reproducible, valid and sensitive to clinically important changes over time. Each of the 12 questions on the OKS is scored in the same way with the score decreasing as the reported symptoms increase (i.e. become worse). All questions are laid out with response categories denoting least (or no) symptoms to the left of the page (scoring 4) and those representing greatest severity lying on the right hand side (scoring 0), as detailed for question 1 below. This method, when summed, produces overall scores running from 0 to 48 with 48 being the best outcome.

次要结局

  • Implant survival [Kaplan-Meier](until 5 years postoperatively)
  • Quality of Life [EQ-5D-5L] compared to baseline(Preoperatively (baseline) and 3 months, 1 year, 2 years, 5 years postoperatively)
  • Progress of Clinical Outcome [Forgotten Joint Score-12] over follow-up period(3 months, 1 year, 2 years, 5 years postoperatively)
  • Radiological assessment: axis alignment (long leg x-ray) over time(at discharge (approx. 7-10 days postoperatively), 3 months, 1 year, 2 years, 5 years postoperatively)
  • Radiological assessment: comparison of tibial slope over time(at discharge (approx. 7-10 days postoperatively), 3 months, 1 year, 2 years, 5 years postoperatively)
  • Radiological assessment: Patella x-ray(at discharge (approx. 7-10 days postoperatively), 3 months, 1 year, 2 years, 5 years postoperatively)
  • Number of Adverse events / serious adverse events over time(During the course of the study up to 5 years postoperatively)
  • Number of Participants with radiological complications over time(During the course of the study up to 5 years postoperatively)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验